David Broecker

David Andrew Broecker (born 1961) is an American life sciences executive. He was president and CEO of Alkermes from 2007 to 2009 and was appointed president and CEO of the Indiana Biosciences Research Institute in 2015. He left that position in 2017.[1]

David A. Broecker
Born1961 (age 61–62)
NationalityAmerican
Alma materWabash College (B.A., 1983)
Massachusetts Institute of Technology (M.S., 1985)
University of Chicago (MBA, 1989)
OccupationBiotechnology executive
Years active1985–2017
Known forPresident and CEO of Alkermes and Indiana Biosciences Research Institute

Education and career

Broecker graduated from Carmel High School, where he led their football team to an undefeated season and the 1978 state 3A championship, tying the Indiana High School Athletic Association record for most touchdown passes in a championship game.[2] He then attended Wabash College, where he majored in chemistry and led the Wabash Little Giants football team to an undefeated season in 1982.[3][4] Broecker won the 1982 National Football Foundation National Scholar-Athlete Award and was inducted into the Wabash College Athletic Hall of Fame twice: as an individual in 1992, and as part of the team he led in 2013.[5]

After graduating summa cum laude and Phi Beta Kappa from Wabash College in 1983, he earned a M.S. degree in chemical engineering from the Massachusetts Institute of Technology in 1985. In 1989 he earned a Master of Business Administration from University of Chicago.[6]

In 1985, Broecker joined Eli Lilly and Company, starting in the medical device and diagnostics division that later became Guidant. He was then involved in development of Ceclor, Prozac, and Zyprexa, overseeing manufacturing operations in Germany and Ireland. In 2001, he was appointed as chief operating officer of Alkermes, later serving as both president and CEO.[7][8] He then held executive positions at BioCritica, ApeX Therapeutics, DiaCarta, and Harlan Laboratories. He founded Zorion Medical in 2010. He was elected a Trustee of Wabash College in 2009.[9]

In 2015, Broecker was appointed President and CEO of the Indiana Biosciences Research Institute (IBRI).[10] In 2016, he announced the IBRI would focus on targeting diabetes, metabolic disease, and poor nutrition.[11] In 2016, the IBRI secured $100 million in grants under his leadership.[12] Broecker was tasked with finding a new location for the IBRI, eventually getting approval for a site to be called 16 Tech.[13] In 2016, Broecker announced that the IBRI had hired Rainer Fischer as Chief Scientific Officer.[14][15] In 2017, Broecker announced that Indiana Governor Eric Holcomb reaffirmed the commitment to the IBRI made in 2013 by his predecessor Mike Pence.[16][17][18]

In September 2018, Broecker was appointed chief innovation and collaboration officer of the Purdue Research Foundation.[19]

References
  1. Swiatek, Jeff (May 19, 2015). "New CEO of bioscience institute looks to hire researchers, raise millions". Indianapolis Star. Retrieved June 25, 2017.
  2. Cavinder, Fred D. (1985). The Indiana Book of Records, Firsts, and Fascinating Facts. Indiana University Press. ISBN 9781625840141.
  3. Amidon, James, Jr. (2017). Glory Reborn: A History of Wabash College and Its Athletic Teams. Kerezy Communications. ISBN 9780692823750.{{cite book}}: CS1 maint: multiple names: authors list (link)
  4. James, Tyler (2013). The Monon Bell Rivalry: Classic Clashes of DePauw vs. Wabash. Arcadia Publishing. ISBN 9781625840141.
  5. "All-Time Football All-Americans". Wabash College. Retrieved June 25, 2017.
  6. "David A. Broecker '83". wabash.edu. Retrieved 5 December 2022.
  7. "People". Nature Biotechnology. Nature Biotechnology 25, 482 (2007). 25 (4): 482. 2007. doi:10.1038/nbt0407-482.
  8. Weisman, Robert (September 12, 2009). "Alkermes chief executive suddenly leaves Cambridge biotech company". Boston Globe. Retrieved June 25, 2017.
  9. Amidon, Jim (May 7, 2009). "Broecker '83 elected Trustee". Wabash College. Retrieved June 25, 2017.
  10. O'Malley, Chris (June 30, 2016). "Bioscience research institute creates a 'petri dish' for innovation". Crain Communications. Retrieved June 25, 2017.
  11. Audretsch, David B. (2015). The Oxford Handbook of Local Competitiveness. Oxford University Press. p. 409. ISBN 9780199993307.
  12. Rudavsky, Shari (February 24, 2016). "New biosciences institute gets $100M". Indianapolis Star. Retrieved June 25, 2017.
  13. Eason, Brian (November 9, 2015). "City-County Council OKs $75M for Indianapolis tech park". USA Today. Retrieved June 25, 2017.
  14. Ober, Andy (October 4, 2016). "IBRI hires European bioscience giant". Inside INdiana Business. Retrieved June 25, 2017.
  15. Russell, John (April 1, 2017). "FOCUS: Biosciences institute's chief scientific officer aims to foster commercialization". Indianapolis Business Journal. Retrieved June 25, 2017.
  16. Redman, Mary-Rachel (January 16, 2017). "Roche CEO: IBRI Will Succeed Where Others Have Failed". Inside INdiana Business. Retrieved June 25, 2017.
  17. Lange, Kaitlin (April 21, 2017). "How Gov. Holcomb's priorities fared in the state budget". Indianapolis Star. Retrieved June 25, 2017.
  18. Heinz, Katie (January 5, 2017). "Governor-elect Eric Holcomb unveils 2017 legislative agenda". WRTV. Retrieved June 25, 2017.
  19. "Veteran entrepreneurial leader named Purdue Research Foundation's chief innovation and collaboration officer". Purdue University. September 12, 2018. Retrieved 2020-08-02.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.